Rein Therapeutics Files DEF 14A, Formerly Aileron Therapeutics
Ticker: RNTX · Form: DEF 14A · Filed: May 12, 2025 · CIK: 1420565
| Field | Detail |
|---|---|
| Company | Rein Therapeutics, Inc. (RNTX) |
| Form Type | DEF 14A |
| Filed Date | May 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance, name-change
TL;DR
Rein Therapeutics (fka Aileron) filed their DEF 14A - check exec comp & governance.
AI Summary
Rein Therapeutics, Inc. filed a DEF 14A on May 12, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and corporate governance matters. Notably, the company was formerly known as Aileron Therapeutics, Inc. and changed its name on March 29, 2024.
Why It Matters
This filing provides insight into the compensation of Rein Therapeutics' top executives and board members, which can influence investor decisions and company strategy.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) detailing executive compensation and corporate governance, not indicating immediate financial distress or significant new risks.
Key Numbers
- 2024 — Fiscal Year End (The filing covers the company's performance and executive compensation for the 2024 fiscal year.)
- 20250512 — Filing Date (This is the date the DEF 14A filing was submitted to the SEC.)
Key Players & Entities
- Rein Therapeutics, Inc. (company) — Filer
- Aileron Therapeutics, Inc. (company) — Former company name
- 20250512 (date) — Filing date
- 2024-12-31 (date) — Fiscal year end
- 20240329 (date) — Date of name change
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is used to solicit proxies from shareholders in connection with annual or special meetings of security holders. It provides detailed information about matters to be voted on, including executive compensation, director elections, and other corporate governance issues.
When was Rein Therapeutics, Inc. formerly known as Aileron Therapeutics, Inc. and when did the name change occur?
Rein Therapeutics, Inc. was formerly known as Aileron Therapeutics, Inc., and the date of the name change was March 29, 2024.
What is the fiscal year end for Rein Therapeutics, Inc. as indicated in the filing?
The fiscal year end for Rein Therapeutics, Inc. is December 31.
What is the SIC code for Rein Therapeutics, Inc. and what industry does it represent?
The Standard Industrial Classification (SIC) code for Rein Therapeutics, Inc. is 2834, which represents Pharmaceutical Preparations.
What is the filing date of this DEF 14A?
The filing date of this DEF 14A for Rein Therapeutics, Inc. is May 12, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 12, 2025 regarding Rein Therapeutics, Inc. (RNTX).